Chronic lymphocytic leukemia (CLL) is the most common type ... anemia abnormal bruising frequent infections The exact cause of CLL isn’t clear, but researchers have identified risk factors ...

Chronic lymphocytic leukemia (CLL) is a type of cancer that affects the blood and bone marrow. It can progress slowly and may not cause many symptoms. Although it is treatable, it’s not ...

Edward Ratner has lived with chronic lymphocytic leukemia for a decade. Here, the Minneapolis doctor shares his rules for success.

Acute leukemia develops quickly and worsens rapidly, but chronic leukemia gets worse over time. In this article, we provide an overview of leukemia, its causes, treatment, type, and symptoms.

One study found most—but not all—patients with chronic lymphocytic leukemia disease progression while taking a Bruton tyrosine kinase inhibitor (BTKi) had a key mutation linked to resistance.

Chronic lymphocytic leukemia (CLL) tends to have a better outlook than most other types of leukemia. About 88% of adults over the age of 20 years live for 5 years post-diagnosis, and some can live ...

Ibrutinib remains a key treatment for relapsed chronic lymphocytic leukemia (CLL), but findings suggest that combining it ...

Immunotherapy research primarily focuses on improving the body’s immune system’s recognition of cancer cells. However, ...

CURE provides access to the cancer news, latest oncology research & expert insights that serve as a guide to every stage of ...

Researchers have found Brukinsa to be a potentially safer alternative for patients with chronic lymphocytic leukemia.

Researchers sought to determine whether zanubrutinib is more beneficial than ibrutinib in patients with CLL/SLL.

and patients were counted a maximum of once per discontinuation reason and could have been counted under multiple discontinuation reasons. CLL denotes chronic lymphocytic leukemia.